Loading…
A preclinical study published in Science Translational Medicine found that a liver-targeted treatment can curb GA1, a rare disease that can cause irreversible brain damage. The approach silences a gene involved in lysine breakdown.
The article also points to blood biomarkers that could help monitor patients.
This is a human medical development with no measurable effect on feed grain, protein or additive supply, demand or prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.